» Articles » PMID: 36005424

Pregnancy Considerations in the Multidisciplinary Care of Patients with Pulmonary Arterial Hypertension

Abstract

Pulmonary arterial hypertension (PAH) is a vasoconstrictive disease of the distal pulmonary vasculature resulting in adverse right heart remodeling. Pregnancy in PAH patients is associated with high maternal morbidity and mortality as well as neonatal and fetal complications. Pregnancy-associated changes in the cardiovascular, pulmonary, hormonal, and thrombotic systems challenge the complex PAH physiology. Due to the high risks, patients with PAH are currently counseled against pregnancy based on international consensus guidelines, but there are promising signs of improving outcomes, particularly for patients with mild disease. For patients who become pregnant, multidisciplinary care at a PAH specialist center is needed for peripartum monitoring, medication management, delivery, postpartum care, and complication management. Patients with PAH also require disease-specific counseling on contraception and breastfeeding. In this review, we detail the considerations for reproductive planning, pregnancy, and delivery for the multidisciplinary care of a patient with PAH.

Citing Articles

When pulmonary arterial hypertension and pregnancy meet: a multidisciplinary clinical experts review.

Dominoni M, Melito C, Schirinzi S, Ghio S, Scelsi L, Greco A Arch Gynecol Obstet. 2024; 310(6):2839-2852.

PMID: 39570387 DOI: 10.1007/s00404-024-07827-1.


Exploring the patient perspective in pulmonary hypertension.

Ford H, Brunetti C, Ferrari P, Meszaros G, Moles V, Skaara H Eur Respir J. 2024; 64(4).

PMID: 39209479 PMC: 11525333. DOI: 10.1183/13993003.01129-2024.


Epoprostenol Exposure During Pregnancy.

Naoum E, LaVita C, Lopez N, Nardone A, Soffer M, Shelton K Crit Care Explor. 2023; 5(6):e0928.

PMID: 37637356 PMC: 10456979. DOI: 10.1097/CCE.0000000000000928.


Health Care Disparities in Pulmonary Arterial Hypertension.

Bernardo R, de Jesus Perez V Clin Chest Med. 2023; 44(3):543-554.

PMID: 37517834 PMC: 10715710. DOI: 10.1016/j.ccm.2023.03.010.

References
1.
Umar S, Rabinovitch M, Eghbali M . Estrogen paradox in pulmonary hypertension: current controversies and future perspectives. Am J Respir Crit Care Med. 2012; 186(2):125-31. PMC: 3406082. DOI: 10.1164/rccm.201201-0058PP. View

2.
Lima F, Yang J, Xu J, Stergiopoulos K . National Trends and In-Hospital Outcomes in Pregnant Women With Heart Disease in the United States. Am J Cardiol. 2017; 119(10):1694-1700. DOI: 10.1016/j.amjcard.2017.02.003. View

3.
Phoophiboon V, Jaimchariyatam N, Srimahachota S, Sirinawin C . Successful multimodality management of severe pulmonary arterial hypertension during pregnancy with VA-ECMO and atrial septostomy using stent. BMJ Case Rep. 2019; 12(12). PMC: 7001717. DOI: 10.1136/bcr-2019-231916. View

4.
Weiss B, Maggiorini M, Jenni R, Lauper U, Popov V, Bombeli T . Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology. 2001; 92(4):1191-4. DOI: 10.1097/00000542-200004000-00039. View

5.
Boucly A, Weatherald J, Savale L, Jais X, Cottin V, Prevot G . Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017; 50(2). DOI: 10.1183/13993003.00889-2017. View